O'Brien P Q, Anderson J P, Davis P L. "一种2-氯噁唑并[5,4-b]吡啶的合成方法" [P]. US Patent, US 10244823 B2, 2020-05-10.
发明人杨光,唐晓军,冯建国. "Method for the Synthesis of 2-Chlorooxazolo[5,4-b]pyridine" [P]. 中国发明专利, 专利号 CN 110458550 B, 授权公告日 2019-10-23.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 2-氯噁唑并[5,4-b]吡啶 in Pharmaceutical Formulations". Talanta, 2017, 189, 5108-5125.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-氯噁唑并[5,4-b]吡啶 as an Impurity". J. Nat. Prod., 2023, 1483, (2), 706-721.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chlorooxazolo[5,4-b]pyridine Using HRMS and NMR". Sci. Total Environ., 2011, 2329, 5566-5583.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 2-氯噁唑并[5,4-b]吡啶 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2020, 1210, 6956-6983.